Concepedia

Richard Lundberg

RL

Statistics

Publications

8

Citations

310

H-Index

8

Active since

1998

Affiliations

Worldwide Clinical Trials (United States)(Current)

Celerion (United States)

MPI Research (United States)

Pharmaceutical Product Development (United States)

Quotient Clinical (United Kingdom)

Richard Lundberg is an author at Worldwide Clinical Trials (United States) specializing in pharmacy, bioanalytical applications, and molecular biology.

ORCID

Publications per year

1998–2012

8

Publications

8

Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis

Steve Lowes, Jim Jersey, Ronald E. Shoup et al. · Bioanalysis · 2011 · 88 citations

, , +13

Deficient DNA End Joining Activity in Extracts from Fanconi Anemia Fibroblasts

Richard Lundberg, Manohara S. Mavinakere, Colin Campbell · Journal of Biological Chemistry · 2001 · 61 citations · Full text

, , +17

Recommendations on The Interpretation of The New European Medicines Agency Guideline on Bioanalytical Method Validation By Global Cro Council For Bioanalysis (Gcc)

Mark Boterman, Mira Doig, Massimo Breda et al. · Bioanalysis · 2012 · 44 citations

, , +15

Deficient Regulation of DNA Double-strand Break Repair in Fanconi Anemia Fibroblasts

Sarah L. Donahue, Richard Lundberg, Rachel Saplis et al. · Journal of Biological Chemistry · 2003 · 33 citations · Full text

, , +17

Recommendations on Bioanalytical Method Stability Implications of Co-Administered And Co-Formulated Drugs By Global Cro Council For Bioanalysis (Gcc)

Steve Lowes, Mark Boterman, Mira Doig et al. · Bioanalysis · 2012 · 32 citations

, , +16

1–5 of 8